| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8739311 | Joint Bone Spine | 2018 | 7 Pages |
Abstract
The prevalence of ACPA in scleroderma is 9.2%. Our meta-analysis shows an increased risk for erosive arthritis, pulmonary fibrosis, oesophagus involvement and diffuse skin involvement, in patients with ACPA-positive SSc. ACPA should be systematically included in SSc assessment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Guillaume Laustriat, Adeline Ruyssen-Witrand, Arnaud Constantin, Thomas Barnetche, Daniel Adoue, Alain Cantagrel, Yannick Degboé,